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Abstract: Background: Cadmium and lead are widespread and non-biodegradable pollutants of great
concern to human health. In real life scenarios, we are exposed to mixtures of chemicals rather
than single chemicals, and it is therefore of paramount importance to assess their toxicity. In this
study, we investigated the toxicity of Cd and Pb alone and as a mixture in an animal model of
acute exposure. Methods: Experimental groups received a single treatment of aqueous solution
of Cd-chloride (15 and 30 mg/kg body weight (b.w.) and Pb-acetate (150 mg/kg b.w.), while the
mixture group received 15 mg Cd/kg b.w. and 150 mg Pb/kg b.w. Toxic effects of individual metals
and their mixture were investigated on hematological and biochemical parameters, and the redox
status in the plasma, liver, and kidneys of treated Wistar rats. Results: Tissue-specific changes were
recorded in various parameters of oxidative damage, while the accumulation of metals in tissues
accompanied the disturbances of both hematological and biochemical parameters. It was observed
that the level of toxic metals in tissues had a different distribution pattern after mixture and single
exposure. Conclusions: Comprehensive observations suggest that exposure to Cd and Pb mixtures
produces more pronounced effects compared to the response observed after exposure to single metal
solutions. However, further research is needed to confirm toxicokinetic or toxicodynamic interactions
between these two toxic metals in the organisms.
Keywords: cadmium; lead; mixture; oxidative stress; toxicity; rats
1. Introduction
Cadmium (Cd) and lead (Pb) are ubiquitous and non-biodegradable pollutants representing a
great concern to human health. Both metals are naturally distributed, but industrial development
has dramatically increased their concentrations in the environment [1–3]. Industries associated with
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smelting and mining, manufacturing of batteries, pigments, and ceramic are well-known emitters of
Cd and Pb. Increased emissions of both metals in the environment and their non-biodegradability
have increased the risk of human exposure. The main routes of Cd and Pb exposure are ingestion and
inhalation due to their presence in food, air, and tobacco leaves [1–4]. The World Health Organization
(WHO) has published a list of 10 chemicals or groups of chemicals of concern for human health,
which includes Cd and Pb [5]. Additionally, the US Agency for Toxic Substances and Disease Registry
(ATSDR) ranked Cd in seventh and Pb in second place on the priority list of dangerous substances [6].
Many in vivo and in vitro studies have been conducted to determine the exact mechanisms of
toxicity of Cd and Pb. The present body of knowledge suggests oxidative stress as one of the critical
mechanisms of toxicity of both metals, even though neither of these metals is a Fenton’s metal [7–10].
Other possible mechanisms of toxicity are binding to oxygen, nitrogen, and sulphur ligands, which
may affect numerous enzymes and proteins [7,11]; interaction with bioelements [12–14]; inhibition of
apoptosis [15]; and changes in DNA structure and the inhibition of damaged DNA repair, which may
lead to aberrant gene expression [16–18].
After absorption, Cd and Pb are distributed in the organisms via red blood cells or proteins [19,20].
A major amount of Cd in red blood cells is bound to high-molecular-weight proteins, while a minor
amount is bound to hemoglobin [19]. However, when Pb enters the cell, most of it is bound to
hemoglobin rather than the membrane of red blood cells [21]. The hematopoietic system is one
of the most sensitive systems and blood represents not only the mode of transportation, but also
the critical toxicity target of Cd and Pb [21,22]. Both metals may lead to anemia by various
mechanisms [2,10,23]. Cadmium and Pb are transported to the liver, in which they can cause damage
and disturbed function. Liver damage can be confirmed by histopathological findings and is often
accompanied by increased blood enzyme levels and reduced protein synthesis [24–28]. Toxic effects
on kidneys are represented through the structure damage of kidneys and changes in the excretory
function [24,25,28,29]. In addition to the metal-toxicity observed in the hematopoietic system, liver,
and kidneys, metals have been implicated in various other organ toxicity. Cadmium has been shown
to exert toxicity in pancreas, endocrine, cardiovascular, immune, and reproductive systems [1,3,30–32],
while Pb toxicity has been linked to toxic effects on the nervous, cardiovascular, and reproductive
systems [2,10,21,33]. The majority of the Pb body burden is in mineralizing tissues (bones and
teeth) [34]. The fact that Cd and Pb have a comparable radius to Ca ions means that both toxic
metals can lead to bone damage by displacing Ca ions [11,35]. The International Agency for Research
on Cancer (IARC) has classified Cd as carcinogenic to humans (Group 1), while inorganic Pb has been
classified as probably carcinogenic to humans (Group 2A) based on limited evidence in humans and
sufficient evidence in animals [21,22,36].
Humans are exposed to mixtures of chemicals rather than an individual chemical, and therefore,
it is important to establish whether chemical mixtures produce a more pronounced effect compared to
individual chemicals. The importance of the evaluation of ”cocktail effects“ has been summarized in the
European Commission statement, which highlighted that even low-level exposure to a complex cocktail
of pollutants over decades could have a significant effect on the health status of European citizens [37].
The co-exposure to Cd and Pb may implicate possible synergism or antagonism, additive, or new
effects that are not observed for single metal exposure [7,38]. A sub-chronic oral toxicity study with
different Cd and Pb doses showed that the main target organs were the blood, liver, and kidneys [24].
Fifteen days following the intraperitoneal administration (i.p.) of a Cd and Pb mixture, Pillai et al. [39]
reported that Cd was the more reactive of the two metals, while Masso et al. [40] suggested a possible
antagonistic effect between Cd and Pb. Clearly, the interactions between the two metals in a combined
mixture are complex and warrant further investigation.
We decided to investigate the toxicity of a Cd and Pb mixture in an animal model of acute
exposure. The effects of the exposure to single metals and their mixture were investigated on
hematological and biochemical parameters and redox status in the plasma, liver, and kidneys of
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treated rats. Furthermore, the distribution of metals and bioelements was investigated in selected
tissues, as well as their histopathology.
2. Materials and Methods
2.1. Chemicals
All reagents and chemicals were of analytical grade quality or higher purity. Cadmium chloride
(CdCl2xH2O, Merck, Germany) and lead acetate (Pb(CH3COO)2x3H2O, Centrohem, Serbia) were
used for oral administration solutions. Standard solutions of Cd, Pb, copper (Cu), and zinc (Zn)
(Merck, Germany) were used to create calibration curves for toxic metals and bioelements analysis,
while cHNO3 (65%, Merck, Germany) and H2O2 (30%, Sigma-Aldrich, Germany) were used for tissue
mineralization. All chemical and reagents for the examination of antioxidant status were purchased
from Sigma-Aldrich Chemie (Germany).
2.2. Animals
Male Wistar rats were purchased from the Military Medical Academy (Belgrade, Serbia).
The experiment was performed on male albino Wistar rats weighing approximately 250 g. Animals
were housed under standard controlled conditions (temperature 25 ± 3 ◦C, relative humidity of 35%
to 60%, 12-h light-dark cycle) and allowed free access to standard rat chow and drinking water during
the experiment. All experimental procedures were approved by the Ethical Committee on Animal
Experimentation of the University of Belgrade, Faculty of Pharmacy (Serbia, project code number
III 46009).
2.3. Study Design and Experimental Procedure
Following two weeks of acclimatization, rats were randomly divided into five groups: one control
group and four experimental groups. Experimental groups that received a single dose of Cd and
Pb were composed of six animals, while the number of rats in the Cd and Pb mixture group was
seven. The control group was composed of eight animals. Experimental groups received a single
treatment of aqueous solution of CdCl2 and/or Pb(CH3COOH)2 in doses: 15 mg Cd/kg body weight
(b.w.) (Cd15 group), 30 mg Cd/kg b.w. (Cd30 group), 150 mg Pb/kg b.w. (Pb150 group), and 15 mg
Cd/kg b.w. and 150 mg Pb/kg b.w. (Cd15 + Pb150 group). The control group was treated with water
only. The selection of experimental doses was based on our previous research, as well as literature
data [24,41,42]. Also, a lower dose of Cd was selected for the mixture treatment in accordance with the
results of our previous research [42]. The treatment of all animals was performed by an oral gavage in
a volume of 1 mL/kg b.w. Animals were sacrificed 24 h after treatment under light anesthesia.
2.4. Tissue Preparations
Blood samples were collected by cardiac puncture through the diaphragm, after anesthetic
administration. One aliquot of blood with anticoagulant (heparin) was used for the measurement of
hematological parameters, and a second aliquot was wet digested for toxic metals and bioelements
measurement. The remaining amount of blood with anticoagulant (heparin) was used to obtain
plasma, while the rest of the blood was collected in test tubes without anticoagulant for obtaining
serum. Plasma and serum were separated and frozen (−80 ◦C for plasma and −20 ◦C for serum) for
redox status and biochemical assays, respectively. Organ systems examined, the liver and kidneys,
were removed and separated into three parts. One tissue sample was immediately frozen in liquid
nitrogen and stored at−80 ◦C for the investigation of antioxidant status, a second was stored at−20 ◦C
for toxic metals and bioelements analysis, and a third tissue sample was preserved in formalin for
histopathological examination.
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2.5. Toxic Metals and Bioelements Analysis
Heparin blood (approximately 1 mL) and wet tissue samples weighing about 500 mg were
placed in Teflon containers with 7 mL cHNO3 and 1 mL H2O2 and mineralized (Milestone START
D, SK-10T, Milestone Srl, Sorisole, Italy). Digestion was carried out according to the Milestone’s
recommendations. The amount of Cd, Pb, Cu, and Zn in the blood and tissue samples was determined
by atomic absorption spectrophotometry (AAS GTA 120 graphite tube atomizer, 200 series AA, Agilent
Technologies, Santa Clara, CA, USA). Matrix modifier, 10% Triton X, and 0.5% NH4H2PO4 have been
used throughout the whole experimental assay. The accuracy of AAS analyses was validated with
standard reference material (SRM) whole blood Level 2 (SeronormTM, Sero, Billingstad, Norway) for
blood analyses and with SRM 1577c - Bovine liver (LGS Standard, UK) for tissue samples.
2.6. Hematology Analysis
Hematological parameters were measured by the CELL-DYN Ruby analyzer (Abbott, Abbott
Park, IL, USA). Multi-angle polarized scatters separation was used for white blood cell and dual
angle optical analysis for platelets count. The following hematological parameters were examined:
white blood cell count (WBC) with WBC differential count (neutrophils, eosinophils, lymphocytes,
basophils, and monocytes), red blood cell count (RBC), hemoglobin concentration (HGB), hematocrit
(HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular
hemoglobin concentration (MCHC), and platelet count (PLT).
2.7. Biochemical Assays
The measured biochemical parameters in rat serum included blood urea nitrogen (BUN),
creatinine (CRE), uric acid (UA), total serum proteins (TP), albumin (ALB), direct bilirubin (DB),
total bilirubin (TB), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline
phosphatase (ALP), amylase (AMY), lactate dehydrogenase (LDH), iron (Fe), calcium (Ca), inorganic
phosphorus (P), magnesium (Mg), and chloride (Cl). All biochemical assays were performed with
commercial reagents and according to good laboratory practices on the Beckman Coulter analyzer (AU
480, Beckman Coulter, Brea, CA, USA). Calibrators of tests were traceable to the National Institute of
Standards and Technology (NIST) SRM and Beckman Coulter Master Calibrators.
2.8. Redox Status Analysis
Tissues samples (liver and kidneys) for redox status assessment were rapidly excised, washed
in ice-cold 0.9% NaCl, and homogenized in nine volumes of buffer (0.1 mol/L phosphate buffer,
pH 7.4) [43]. Homogenization was carried out by the T10 basic Ultra-Turrax homogenizer (IKA,
Staufen, Germany). A portion of homogenate was used for the determination of malondialdehyde
(MDA), while the rest was centrifuged for 10 min (at 4 ◦C) at 800 g and then for 20 min at
9500 g to get post-mitochondrial supernatant (PMS). Assessment of the following parameters was
performed: MDA, advanced oxidation protein products level (AOPP), total thiol (SH) groups level,
prooxidative-antioxidative balance (PAB), total antioxidative status (TAS), total oxidative status
(TOS), oxidative stress index (OSI), and superoxide dismutase activity (SOD) at ILAB 300 plus
analyzer (Instrumentation Laboratory, Milan, Italy) and Cary 60 UV-VIS spectrophotometer (Agilent
Technologies, Santa Clara, CA, USA).
The concentration of MDA was determined as a thiobarbituric acid-reactive substance (TBARS)
by a spectrophotometric assay based on the absorption maximum of the malondialdehyde complex
and other TBARS with thiobarbituric acid at 535 nm [44]. The principle of the method for determining
AOPP is a two-step measurement of sample absorption in the wavelength range of 200–400 nm, with a
characteristic peak at 340 nm. The obtained difference in the measured absorbance values of 340 nm
indicates the AOPP value for the given sample [45]. The principle of the method for determining
the total SH-groups is as follows: aliphatic thiol compounds in the base environment are reacted
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with DTNB (2,2’-dinitro-5,5’-dithio-benzoic acid), wherein one mol of thiol produces one mol of
p-nitrophenol. The resulting color has an absorption peak at 412 nm [46]. Alamandari et al. [47] have
developed a method for the determination of PAB using 3,3’,5,5’-tetramethylbenzidine as a chromogen.
The method principle for TAS assessment is as follows: the colorless reduced form of ABTS is oxidized
to dark green color ABTS+ with hydrogen peroxide in an acidic medium (acetate buffer 30 mM,
pH 3.6) [48]. The TOS method is based on oxidants present in the sample to oxidize the ferrous ion
from the o-dianisidine complex to ferric ion. The build-up intensity is directly proportional to the
concentration of oxidants present in the sample, with an absorption peak at 560 nm [49]. Oxidative
stress degree was calculated as the ratio between TOS and TAS [50]. The method of determining the
activity of superoxide dismutase enzymes (SOD, EC 1.15.1.1.) was established in 1971 by Misra and
Fridovich [51]. The method is based on the ability of SOD to inhibit the spontaneous autoxidation of
adrenaline at pH 10.2. Protein levels in tissues were determined by the Bradford method [52] using
bovine albumin as the standard, while plasma protein levels were determined by the standard biuret
method [53].
2.9. Histopathological Analysis
The preserved tissues (liver and kidneys) were subjected to histopathological examination.
Microscopic examinations on paraffin embedded 5 µm tissue sections with hematoxylin-eosin were
performed. Each section was examined under an optical microscope.
2.10. Statistical Analysis
Statistical analysis was performed using SPSS 18.0 (SPSS Inc. Chicago, IL, USA) software. One-way
ANOVA and Kruskal-Wallis nonparametric tests were used. These statistical tests were followed by LSD
or the Mann-Whitney U test, respectively. p-Values less than 0.05 were considered significant.
3. Results
3.1. Cadmium and Lead Concentration in Tissues
Experimental groups treated with a single dose of Cd had a statistically higher blood concentration
of Cd compared to values in the control group. Blood concentrations of Cd in the Cd-Pb mixture
group were not different from control values. Both experimental groups receiving a single dose of Cd
(15 or 30 mg/kg) demonstrated significantly higher levels of Cd in the liver compared to the control
group (p < 0.001), while the Cd30 group had a higher concentration of Cd in the liver compared to the
Cd15 group (p < 0.01). The measured level of liver Cd in the experimental group receiving Cd and Pb
mixture exhibited a statistically significant difference when compared to the control, while difference
from the Cd15 group was not observed. Additionally, both Cd groups (Cd15 group and Cd30 group)
showed statistically significant higher levels of Cd in kidneys compared to the control group (p < 0.001).
Experimental groups treated with 30 mg Cd/kg b.w. had a higher concentration of Cd in the kidneys
compared to 15 mg Cd/kg b.w. (p < 0.05). After mixture treatment, the Cd concentration in the kidneys
showed a statistically significant difference when compared to the control and Cd15 group (p < 0.001,
p < 0.01, respectively).
Experimental groups that received Pb had higher concentrations of lead in all three of the
investigated mediums: blood, liver, and kidneys, compared to values in the control group. Additionally,
the Cd15 + Pb150 group had a statistically higher Pb concentration in the liver and kidneys compared
to the Pb150 group (p < 0.01, p < 0.05 respectively), while the difference was not observed in blood.
Levels of Cd and Pb in investigated tissues are shown in Figures 1 and 2.
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Cadmium levels in blood are expressed as µg Cd/L and as µg Cd/kg (wet tissues) in liver and 
kidneys. Values are presented as means and S.D. Statistically significant differences (p < 0.05) 
compared to control group are indicated by *, † Cd15 group. Statistical evaluation was performed 
using one-way ANOVA followed by LSD post-hoc test for pairwise comparison. * † p < 0.05; ** †† p < 
0.01; *** ††† p < 0.001. 
 
Figure 2. Lead concentration in rat blood, liver, and kidneys after acute exposure to Cd and Pb. Lead 
levels in blood are expressed as µg Pb/L and as µg Pb/kg (wet tissues) in liver and kidneys. Values 
are presented as means and S.D. Statistically significant differences (p < 0.05) compared to control 
group are indicated by *, ‡ Pb150 group. Statistical evaluation was performed using one-way ANOVA 
followed by LSD post-hoc test for pairwise comparison. * ‡ p < 0.05; ** ‡‡ p < 0.01; *** ‡‡‡ p < 0.001. 
3.2. Hematology 
Higher doses of Cd produced a significant decrease in the WBC number compared to the 
control group and to a lower dose of Cd (p < 0.001, p < 0.01, respectively), while there was no 
difference in the group receiving the mixture. The change in absolute lymphocyte count had a 
similar trend, and the Cd30 group exhibited a lower count compared to values from the control and 
Cd15 groups (both, p < 0.01). A lower dose of Cd also produced a significant decrease in contrast to 
the control group (p < 0.01). Following the administration of Pb, we observed significantly higher 
absolute neutrophils counts in only the group that received the mixture of toxic metals in contrast to 
control values (p < 0.05), while single Pb treatment did not produce any changes in WBC count. 
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Figure 1. Cadmium concentration in rat blood, liver, and kidneys after acute exposure to Cd and Pb.
Cadmium levels in blood are expressed as µg Cd/L and as µg Cd/kg (wet tissues) in liver and kidneys.
Values are presented as means and S.D. Statistically significant differences (p < 0.05) compared to control
group are indicated by *, † Cd15 group. Statistical evaluation was performed using one-way ANOVA
followed by LSD post-hoc test for pairwise comparison. * † p < 0.05; ** †† p < 0.01; *** ††† p < 0.001.
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Figure 2. Lead concentration in rat blood, liver, and kidneys after acute exposure to Cd and Pb.
Lead levels in blood are expressed as µg Pb/L and as µg Pb/kg (wet tiss es) in liver and kidneys.
Values are presented as means and S.D. Statistically significant differences (p < 0.05) compared to control
gro p are indicated by *, ‡ Pb150 group. Statistic l evaluation was performed sing one-way ANOVA
followed by LSD post-hoc test for pairwise comparison. * ‡ p < 0.05; ** ‡‡ p < 0.01; *** ‡‡‡ p < 0.001.
3.2. Hematology
Higher doses of Cd produced a significant decrease in the WBC number compared to the control
group and to a lower dose of Cd (p < 0.001, p < 0.01, respectively), while there was no difference in the
group receiving the mixture. The change in absolute lymphocyte count had a similar trend, and the
Cd30 group exhibited a lower count compared to values from the control and Cd15 groups (both,
p < 0.01). A lower dose of Cd also produced a significant decrease in contrast to the control group
(p < 0.01). Following the administration of Pb, we observed significantly higher absolute neutrophils
counts in only the group that received the mixture of toxic metals in contrast to control values (p < 0.05),
while single Pb treatment did not produce any changes in WBC count.
In all experimental groups, we noticed a decreasing trend in RBC, HGB, and HCT levels compared
to values obtained from the control group, yet there was no difference between the treated groups.
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The most pronounced effects were observed in the Cd30 group and Cd15 + Pb150 group (for all three
parameters, p < 0.001). Significant changes in MCH were noticed in both Cd-treated groups (Cd15
group and Cd30 group) when compared to the controls. Neither MCV nor MCHC was affected by
the treatment.
Platelet count was significantly increased in the Cd15 group (p < 0.01), but decreased in the Cd30
group, in contrast to control. The Pb given as a single chemical achieved a statistically significant
decrease in the PLT count compared to the control group, while Pb given in the mixture only produced
a reduction in PLT when compared to the same single dose of Cd (p < 0.001). Observed hematological
parameters are shown in Table 1.
Table 1. Effect of Cd or/and Pb on hematological parameters in rats after acute exposure.
Control Group Cd15 Group Cd30 Group Pb150 Group Cd15 + Pb150 Group
WBC (109/L) 1 3.85 ± 0.68 3.56 ± 0.53 2.36 ± 0.32 *** †† 4.08 ± 0.75 3.97 ± 0.66
Lymphocyte
(109/L) 2
2.58
1.84–2.94
1.84 **
1.36–2.11
1.15 ** ††
1.01–1.16
2.54
2.18–2.77
2.22
1.44–2.69
Neutrophils
(109/L) 2
1.02
0.80–1.41
1.21
0.73–1.99
0.88
0.75–1.18
1.27
0.81–1.43
1.23 *
0.95–2.14
RBC (1012/L) 1 6.91 ± 0.25 5.61 ± 0.98 *** 5.05 ± 0.61 *** 5.74 ± 0.67 ** 5.19 ± 0.74 ***
HGB (g/L) 2
148.0
143.0–161.0
139.0 *
105.0–154.0
117.5 ***
104.0–128.0
126.5 *
118.0–153.0
117.0 ***
94.0–127.0
HCT (L/L) 2
0.401
0.380–0.410
0.343 *
0.250–0.410
0.314 ***
0.260–0.340
0.336 *
0.300–0.420
0.303 ***
0.210–0.340
MCV (fL) 2
58.0
56.0–61.0
58.0
57.0–62.0
60.5
56.0–69.9
60.0
56.0–63.0
58.0
56.0–59.0
MCH (pg) 2
21.0
20.0–23.0
23.5 **
22.0–25.0
23.0 *
22.0–26.0
22.5
22.0–24.0
22.0
21.0–26.0
MCHC (g/L) 2
370.0
361.0–390.0
398.0
379.0–420.0
386.5
349.0–409.0
383.0
361.0–397.0
379.0
372.0–447.0
PLT (109/L) 1 571.25 ± 43.03 701.00 ± 40.30 ** 341.50 ± 92.36 *** ††† 449.50 ± 100.60 ** 525.00 ± 53.86 †††
1 Values are presented as means ± standard deviation. 2 Values are presented as medians and ranges.
WBC = white blood cell count; RBC = red blood cell count; HGB= hemoglobin; HCT = hematocrit; MCV = mean
corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration;
PLT = platelet count. Parameters that were not influenced by Cd and Pb treatment are not listed. Statistically
significant differences (p < 0.05) compared to control group are indicated by *, † Cd15 group, ‡ Pb150 group.
Statistical evaluation was performed using one-way ANOVA and Kruskal-Wallis nonparametric test followed by
LSD and Mann-Whitney U test for pairwise comparison. * † ‡ p < 0.05; ** †† ‡‡ p < 0.01; *** ††† ‡‡‡ p < 0.001.
3.3. Biochemical Assays
Acute exposure to the investigated toxic metals administered alone or in mixture form resulted in
the altered profile of some biochemical parameters. All experimental groups had lower concentrations
of urea compared to the control group, while there was a slight increase in creatinine levels in all
experimental groups, only reaching significance in the Cd30 group and Pb150 group when compared
to the controls (p < 0.01, p < 0.05, respectively). Total proteins and albumin levels were lower after
exposure to a mixture relative to the control group (p < 0.01, p < 0.05, respectively). Additionally,
mixture treatment caused a lower proteins level (p < 0.05) in contrast to the Pb150 group. An elevated
level of direct bilirubin was observed in the Pb150 group in comparison to the control, while total
bilirubin was at least slightly increased in all experimental groups, with only the values from the Cd15
group and Cd30 group reaching statistical significance compared to the control. Exposure to either
toxic metal did not affect the levels of uric acid across all treatment groups.
All experimental groups had lower concentrations of serum iron compared to the control
(p < 0.001), without any difference among dosing groups. Change in calcium levels was towards
reduction, but statistical significance was only achieved in groups that received Pb, with a more
pronounced effect in the mixture (p < 0.01). A similar trend was noticed for magnesium levels,
with reductions not only after Pb administration, but also following the dose of 30 mg Cd/kg b.w.
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Furthermore, differences within the groups were not observed for either calcium or magnesium.
Phosphorus levels were only significantly lower after the administration of 30 mg/kg b.w. Cd when
compared to the control (p < 0.05). Changes in chloride levels were observed in the group receiving Pb
as a single metal and in a group receiving a higher Cd dose when compared to the untreated group,
whereas after the application of the mixture, chlorine levels were significantly different, but only for
the individual Pb dose group (p < 0.01). Observed biochemical parameters are shown in Table 2.
Table 2. Effect of Cd or/and Pb on biochemical parameters in rat serum after acute exposure.
Control Group Cd15 Group Cd30 Group Pb150 Group Cd15 + Pb150 Group
BUN (mmol/L) 1 10.72 ± 1.02 8.56 ± 0.82 *** 8.76 ± 1.08 ** 8.76 ± 1.12 ** 9.08 ± 1.13 **
CRE (µmol/L) 2
42.45
39.5–43.4
44.75
35.5–53.4
45.45 **
42.8–53.4
43.40 *
41.4–46.7
43.40
40.5–46.1
TP (g/L) 2
59.0
53.4–63.3
60.3
45.3–74.2
61.8
53.4–64.9
59.5
55.1–66.8
52.4 ** ‡
48.7–58.0
ALB (g/L) 2
32.1
29.4–35.7
28.8
22.5–36.6
30.3
27.0–33.4
30.7
29.9–32.1
28.8 *
26.3–32.0
DB (µmol/L) 2
0.4
0.3–0.5
0.45
0.2–0.5
0.4
0.3–0.6
0.7 **
0.7–0.9
0.4 ‡‡
0.4–0.6
TB (µmol/L) 1 2.04 ± 0.16 2.56 ± 0.33 ** 2.38 ± 0.38 * 2.24 ± 0.16 2.18 ± 0.14 †
Fe (µmol/L) 1 61.7 ± 11.4 27.5 ± 8.8 *** 21.6 ± 5.8 *** 36.3 ± 10.5 *** 31.4 ± 6.3 ***
Ca (mmol/L) 2
2.93
2.5–3.2
2.73
2.2–3.2
2.65
2.5–3.1
2.65 *
2.5–2.9
2.48 **
2.2–2.7
Mg (mmol/L) 2
1.70
1.5–1.9
1.55
1.1–2.2
1.30 *
1.3–1.8
1.35 ***
1.0–1.5
1.30 ***
1.1–1.5
P (mmol/L) 2
3.05
3.0–3.4
2.87
2.6–4.4
2.71 *
2.4–3.3
3.15
2.9–3.2
3.05
2.1–3.4
Cl (mmol/L) 2
105.0
102.0–109.0
110.5
102.0–118.0
108.5 *
105.0–116.0
113.0 ***
108.0–118.0
106.0 ‡‡
100.0–109.0
1 Values are presented as means ± standard deviation. 2 Values are presented as medians and ranges. Blood urea
nitrogen (BUN), creatinine (CRE), total serum proteins (TP), albumin (ALB), direct bilirubin (DB), total bilirubin
(TB), iron (Fe), calcium (Ca), magnesium (Mg), inorganic phosphorus (P), chloride (Cl). Parameters that were
not influenced by Cd and Pb treatment are not listed. Statistically significant differences (p < 0.05) compared to
control group are indicated by *, † Cd15 group, ‡ Pb150 group. Statistical evaluation was performed using one-way
ANOVA and Kruskal-Wallis nonparametric test followed by LSD and Mann-Whitney U test for pairwise comparison.
* † ‡ p < 0.05; ** †† ‡‡ p < 0.01; *** ††† ‡‡‡ p < 0.001.
All experimental groups exhibited a downward trend in ALT activity, and a statistically significant
effect at the higher dose of Cd (p < 0.05), as well as in both groups receiving Pb, when compared to the
controls. On the other hand, only mixture administration reduced AST activity (p < 0.05) compared
to Pb given alone. Both Cd doses decreased ALP activity compared to the control group (p < 0.001),
and higher Cd doses significantly decreased ALP activity (p < 0.05) compared to lower Cd doses.
Similarly, experimental groups receiving Pb and the mixture showed a decrease in ALP activity relative
to the control group (p < 0.001). LDH activity was decreased after 30 mg/kg b.w. Cd administration in
contrast to the untreated controls and the Cd15 group (p < 0.05, p < 0.01, respectively), while changes
in AMY activity were not observed. Investigated enzyme activities in rat serum are shown in Figure 3.
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Statistically significant differences (p < 0.05) compared to control group are indicated by *, † Cd15 
group, ‡ Pb150 group. Statistical evaluation was performed using one-way ANOVA followed by LSD 
post-hoc test for pairwise comparison. * † ‡ p < 0.05; ** †† ‡‡ p < 0.01; *** ††† ‡‡‡ p < 0.001. 
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AOPP concentration was increased in all experimental groups receiving a single metal, yet we did 
not observe any differences between these groups. AOPP levels after mixture treatment were similar 
to control values, but were observed to be lower when compared to a single Cd dose. Other redox 
parameters, such as MDA, SH-groups, and SOD activity, were not altered in rat liver after acute 
exposure to toxic metals. The higher dose of Cd produced significant increases in kidney MDA 
levels when compared to the group treated with a lower Cd dose (p < 0.05). Elevated MDA levels 
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Fig re 3. E fect of Cd or/and Pb on serum enzy e ies in rats ft r rtate
a inotransferase ( ST), alanine a inotransferase (ALT), and alkaline osphatase ( LP) are
re rese te on anel (a), il l t t r ( ) a el ( ). r t rs t at ere ot
i fl e ce by Cd and Pb treatment are not listed. Values are presented as means and S.D. Statistically
significant differences (p < 0.05) compared to control group are indicated by *, † Cd15 group, ‡ Pb150
group. Statistical evaluation was performed using one-way ANOVA followed by LSD post-hoc test for
pairwise comparison. * † ‡ p < 0.05; ** †† ‡‡ p < 0.01; *** ††† ‡‡‡ p < 0.001.
3.4. Redox Status
Blood MDA level was increased after the administration of 30 mg/kg b.w. Cd, but only when
compared to the lower Cd dose (p < 0.05). After exposure to the mixture, both MDA and AOPP blood
levels were increased compared to groups receiving single metal. Additionally, mixture treatment
induced a significant elevation of blood AOPP compared to control values (p < 0.001). We did
not observe any toxic metal-induced changes in the overall levels of SH-groups and PAB in blood.
Liver AOPP concentration was increased in all experimental groups receiving a single metal, yet we did
not observe any differences between these groups. AOPP levels after mixture treatment were similar
to control values, but were observed to be lower when compared to a single Cd dose. Other redox
parameters, such as MDA, SH-groups, and SOD activity, were not altered in rat liver after acute
exposure to toxic metals. The higher dose of Cd produced significant increases in kidney MDA levels
when compared to the group treated with a lower Cd dose (p < 0.05). Elevated MDA levels were
observed in both Pb treatment groups, with more pronounced effects after treatment with the mixture
compared to the controls (p < 0.001). Furthermore, mixture administration produced a significant
elevation in MDA concentration in the kidney compared to a single Cd dose (p < 0.01). AOPP levels,
SH-groups, and SOD activity remained unchanged in kidneys after toxic metals treatments. Observed
redox parameters in rat blood, liver, and kidneys are presented in Table 3.
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Table 3. Redox parameters in rat blood, liver, and kidney after Cd or/and Pb acute exposure.
Control Group Cd15 Group Cd30 Group Pb150 Group Cd15 + Pb150 Group
Blood
MDA (µmol/L) 2.231.99–3.68
1.94
1.49–2.82
2.66 †
2.17–3.13
2.10
1.62–2.46
2.41 † ‡
2.16–3.21
AOPP (µmol/g
protein)
1.84
1.67–2.19
1.40 *
1.20–1.95
1.97
1.26–3.68
2.34
1.53–6.04
13.53 *** ††† ‡‡‡
9.94–16.59
SH-groups
(mmol/L)
0.12
0.08–0.21
0.16
0.10–0.22
0.13
0.10–0.13
0.16
0.13–0.26
0.18
0.13–0.27
PAB (HCU) 136.6105.3–181.6
186.2
169.0–215.9
189.6
144.3–203.5
191.0
133.6–201.4
128.6
87.2–150.0
Liver
MDA (µmol/mg
protein)
80.1
56.77–95.52
75.76
64.08–89.08
104.75
68.64–124.80
77.15
36.59–101.19
76.59
62.66–98.31
AOPP (µmol/g
protein)
83.16
35.82–166.36
234.84 ***
172.37–252.13
201.66 ***
179.94–324.36
178.99 *
114.81–228.23
81.42 ††
38.05–194.69
SH groups
(mmol/g protein)
0.31
0.25–0.33
0.31
0.22–0.38
0.30
0.25–0.40
0.31
0.20–0.39
0.27
0.15–0.36
SOD (U/g) 56.9252.07–60.82
53.56
45.54–57.35
52.8
048.47–59.67
55.70
47.77–60.65
52.45
51.48–63.25
Kidneys
MDA (µmol/mg
protein)
209.42
132.68–232.39
171.94
143.99–253.74
237.65 †
194.81–397.13
283.88 *
197.42–328.57
273.15 *** ††
233.25–321.88
AOPP (µmol/g
protein)
273.68
153.97–341.22
255.58
206.36–317.21
286.65
250.53–360.61
297.75
231.56–368.82
273.79
226.38–362.08
SH groups
(mmol/g protein)
0.27
0.18–0.34
0.25
0.17–0.39
0.25
0.21–0.35
0.24
0.22–0.30
0.27
0.17–0.31
SOD (U/g) 62.3137.84–74.04
57.02
46.90–63.07
52.56
46.88–70.01
61.83
50.54–73.51
60.65
37.58–76.60
Values are presented as medians and ranges. Malondialdehyde (MDA), advanced oxidation protein products level
(AOPP), total thiol (SH) groups level, prooxidative-antioxidative balance (PAB) expressed in arbitrary hydrogen
peroxide complementary units (HCU), superoxide dismutase activity (SOD). Observed parameters are expressed
on wet tissues. Parameters that were not influenced by Cd and Pb treatment are not listed. Statistically significant
differences (p < 0.05) compared to control group are indicated by *, † Cd15 group, ‡ Pb150 group. Statistical
evaluation was performed using the Kruskal-Wallis nonparametric test followed by Mann-Whitney U test for
pairwise comparison. * † ‡ p < 0.05; ** †† ‡‡ p < 0.01; *** ††† ‡‡‡ p < 0.001.
Total antioxidative status, total oxidative status, and oxidative stress index in rat plasma, liver,
and kidneys are presented in Figure 4. Blood TOS levels were increased in all experimental groups
exposed to a single metal, but the increase was only significant in the Cd30 group and Pb150 group
compared to control values. TAS content was inversely affected by the type of metal treatment. Groups
receiving a single metal had lower blood TAS levels compared to the control, but TAS levels were
significantly higher in the mixture group compared to groups treated with a single metal. The degree
of oxidative stress in blood was calculated as the ratio between TOS and TAS, which exhibited an
upward trend after exposure to individual metals. Only in the highest dose, the Cd30 and Pb150 groups,
did this trend reach statistical significance. The most robust effect in the liver was observed after
exposure to a single Pb dose (p < 0.01), resulting in a reduction in TAS content compared to the control
group. Moreover, the highest liver OSI index value was noticed in the Pb150 group, which was in line
with the lowered TAS value. No statistically significant changes were observed in kidney TOS and
TAS levels compared to the control group, hence the OSI index also remained unchanged.
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approximately equal to zero when the sum of all the analytes is approximately the average of normal 
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Figure 4. Effect of Cd or/and Pb on total antioxidative status (TAS, panel (a–c)), total oxidative
status (TOS, panel (d–f)), and oxidative stress index (OSI, panel (g–i)) values in rat blood, liver,
and kidney after acute exposure. Levels of TAS and TOS are expressed on wet tissues. The box
represents interquartile range (25–75th percentile), the line within the box represents median value,
and ends of the whiskers represent the minimum and maximum values within the group. Statistically
significant differences (p < 0.05) compared to control group are indicated by *, † Cd15 group, ‡ Pb150
group. Statistical evaluation was performed using the Kruskal-Wallis nonparametric test followed by
Mann-Whitney U test for pairwise comparison. * † ‡ p < 0.05; ** †† ‡‡ p < 0.01; *** ††† ‡‡‡ p < 0.001.
The obtained redox parameters after acute xposure with Cd r/and Pb were used to calculate
three scores: a score of oxidative damage (DS), a score of antioxid tive defenses (protection scor , PS),
and the so-called OXY-score (as a global score of oxidative balance). The protection score was calculated
as an average of standardized antioxidant variables by calculating Z scores (TAS, SOD, and SH-groups),
while the damage score was calculated as an average of standardized prooxidant factors by calculating
Z scores (TOS, PAB, MDA, and AOPP). The OXY-score was calculated by subtracting the PS from
the DS using the equation given by Veglia et al. [54]. The OXY-score is approximately equal to zero
when the sum of all the analytes is approximately the average of normal values, or the high level of
damage markers is compensated for by high levels of antioxidant protection [54]. After evaluating the
obtained results for calculating the oxidative damage score in all three investigated mediums, DS was
positively correlated with different doses of Cd, but a significant correlation was only observed with a
higher Cd dose. Additionally, a significant correlation was detected in the Pb150 group. The parameters
used to calculate antioxidative defenses had a lower trend in all investigated groups, and the overall
protection score was lower than the control, but these changes were not significant. Overproduction
of pro-oxidant versus antioxidative protection in the Cd30 group and Pb150 group resulted in a high
OXY-score value, indicating higher oxidative damage in these two experimental groups. Observed
oxidative stress scores are presented in Table 4.
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Table 4. Oxidative stress score after acute exposure to Cd or/and Pb in rats.
Control Group Cd15 Group Cd30 Group Pb150 Group Cd15 + Pb150 Group
Damage score −0.083 ± 0.49 0.088 ± 0.51 0.526 ± 0.26 * 0.485 ± 0.24 * −0.254 ± 0.39 ‡
Protection score −0.038 ± 0.34 −0.37 ± 0.56 −0.29 ± 0.24 −0.11 ± 0.37 −0.22 ± 0.63
OXY-score −0.045 ± 0.58 0.46 ± 0.89 0.81 ± 0.39 * 0.77 ± 0.30 * −0.037 ± 0.80 ‡
Values are presented as means ± standard deviation. Statistically significant differences (p < 0.05) compared to
control group are indicated by *, † Cd15 group, ‡ Pb150 group. Statistical evaluation was performed using one-way
ANOVA followed by LSD post-hoc test for pairwise comparison.
3.5. Bioelements Levels in Tissues
Experimental groups treated with 15 mg Cd/kg b.w. had lower blood Cu levels in comparison
to the controls (p < 0.001). After mixture treatment, blood Cu levels were in line with the control
and Pb150 group, but higher than the Cd15 group (p < 0.001). On the other hand, the most prominent
decrease of blood Zn level was observed after exposure to 30 mg Cd/kg b.w. in contrast to the control
and Cd15 group (p < 0.05, p < 0.001, respectively). Following metal mixture treatment, blood Zn levels
were lower compared to each of the individual metal treatment groups (p < 0.05).
Treatment with the higher Cd dose resulted in a significant elevation in liver Cu levels over control
values (p < 0.01). Furthermore, both Pb-treated groups exhibited increased liver Cu levels, with the
most prominent elevation after mixture treatment (p < 0.01). Levels of Zn in the liver were increased
after all dose regimes, but Pb treatments produced the most pronounced one. Namely, in both Pb
groups, we observed a significant elevation in Zn levels compared to control values (p < 0.001).
Both Cd groups (Cd15 and Cd30) had lower renal Zn levels compared to controls (p < 0.001).
A significant decrease in renal Zn levels was also observed after Pb treatments compared to the control.
Following administration of the mixture, renal Zn levels were higher than after single Cd treatment,
but similar to the Pb150 group. Bioelement levels in the rat blood, liver, and kidney are presented in
Table 5.
Table 5. Levels of Cu and Zn in rat blood, liver, and kidney after acute exposure to Cd or/and Pb.
Blood Liver Kidney
Cu (µmol/L) Zn (µmol/L) Cu (µmol/kg) Zn (µmol/kg) Cu (µmol/kg) Zn (µmol/kg)
Control group 22.10 ± 1.81 87.76 ± 3.24 50.74 ± 2.80 462.77 ± 57.37 96.92 ± 10.39 374.18 ± 38.14
Cd15 group 16.09 ± 1.22 *** 93.19 ± 8.61 57.60 ± 5.58 585.16 ± 90.11 ** 79.27 ± 4.06 299.70 ± 25.88 ***
Cd30 group 20.00 ± 2.34 †† 74.20 ± 15.81 * ††† 65.08 ± 10.48 ** 576.49 ± 43.11 * 88.27 ± 21.02 310.47 ± 12.89 ***
Pb150 group 20.59 ± 2.40 92.23 ± 7.62 63.26 ± 3.65 * 613.06 ± 24.48 *** 110.95 ± 22.11 329.07 ± 22.95 **
Cd15 + Pb150 group 20.19 ± 1.53 ††† 81.04 ± 7.34 † ‡ 67.00 ± 13.17 ** 609.78 ± 102.73 *** 95.42 ± 11.37 336.67 ± 24.44 * †
Values are presented as means ± standard deviation. Levels of Cu and Zn are expressed as µmol/L in blood and
as µmol/kg in liver and kidney (wet tissues). Statistically significant differences (p < 0.05) compared to control
group are indicated by *, † Cd15 group, ‡ Pb150 group. Statistical evaluation was performed using one-way ANOVA
followed by LSD post-hoc test for pairwise comparison. * † ‡ p < 0.05; ** †† ‡‡ p < 0.01; *** ††† ‡‡‡ p < 0.001.
3.6. Histopathological Analysis
Histopathological examination in the liver of control rats showed normal architecture (Figure 5a).
The Cd15 group cross-section showed very lightly dilated sinusoids with lymphocytic infiltrate in
the portal spaces of the liver (Figure 5b), while lightly to moderately dilated sinusoids with mixed
lymphocytic and neutrophilic infiltrate in the portal spaces were observed in the Cd30 group (Figure 5c).
Lightly dilated sinusoids with mixed lymphocytic and neutrophilic infiltrate in the portal spaces,
around biliary ducts, were observed in the Pb150 group. Additionally, scattered mononuclear cells
in sinusoids were present. In zone 1 of the acinus, clear hepatocyte cytoplasm with condensed
chromatin in nuclei was observed in the Pb150 group, while venous thrombus was present in only
one of the examined tissues (Figure 5d). Treatment with the metal mixture resulted in a pattern
of changes observed in the Pb treatment group, but the changes were more prominent (Figure 5e).
The cross-section in the kidneys of the control group showed normal architecture, while in all treated
groups, acute passive hyperemia without significant pathologic changes was observed.
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4. Discussion
4.1. Effects on the Hematopoietic System
In general, the uptake, distribution, and accumulation of metals in the tissues and organs depend
on many factors, such as the metals’ characteristics and forms, route, dose and exposure duration,
the ability for binding to ligands in the cells, and species sensitivity. The hematopoietic system is one
of the most sensitive organs to assess the toxicity. After oral administration, both Cd and Pb undergo
intestinal absorption and are transported via blood. In the blood, they can be distributed via red
blood cells and plasma proteins, mainly albumin [19,20]. Both Cd-treated groups had a significantly
higher blood Cd concentration in comparison to the unexposed group, while there were no differences
observed between Cd-treatment groups. It could be hypothesized that explanations for this occurrence
are limited to gastrointestinal absorption, saturation of Cd binding sites in the blood, or fast clearance
from the blood. On the other hand, analysis of toxic metals in the blood of experimental animals
treated with a mixture showed some interesting trends. Namely, blood Cd concentration was lower
than in the Cd15 group and it was in line with values we observed in the control group, while blood
Pb concentration was higher than in the corresponding Pb group. Possible reasons for this observation
might be the differences in their bioavailability and their competitive affinity to protein transporters
following oral administration with possible antagonism involvement [55,56]. A similar observation
was noted by Masso et al. [40] using dams that were consuming a solution of Cd (10 mg/L) and Pb
(300 mg/L) from the first day of pregnancy and using the blood taken from pups at day 0 of parturition
and the end of lactation. Co-exposure to these toxic metals resulted in diminished blood levels of both
metals in contrast to single metal treatment, so the authors suggested a possible antagonistic effect due
to gastrointestinal interactions.
Our data showed that both Cd doses led to absolute lymphopenia, with a more pronounced effect
at the higher Cd dose, where lymphopenia was accompanied by leucopenia. Similar toxic effects of
Cd on lymphocyte count were observed after single Cd treatment in rats [26,57], after 14 days of Cd
administration in male BALB/c mice [58], and after four-week treatment of Wistar rats with CdCl2
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via drinking water [28,59]. One possible cause of the leucopenia after a single Cd treatment in our
study is that increased destruction of WBC is caused by Cd. We measured high levels of both metals
in the spleen and thymus of treated animals after Cd administration (data are not shown). Lafuente
et al. [60] showed high levels of Cd in the spleen and thymus after oral CdCl2 treatment with doses
of 25–100 ppm, as well as decreased B lymphocytes levels in the spleen and thymus, suggesting that
direct tissue toxicity is caused by Cd accumulation. Literature describing the Pb effect is conflicting,
with some studies pointing to unchanged WBC status [25,61], leukocytosis [29], and leucopenia [62].
Neutrophilia with moderate leukocytosis observed in this study after mixture administration could be
the result of neutrophil release and mobilization under inflammatory IL-6 and TNF-α from marginal
neutrophil pools [63,64].
Administration of either of the toxic metals decreased RBC, HGB, and HCT, with the mixture
group showing the largest effects. Namely, the percent decrease in RBC, HGB, and HCT ranged from
10 to 20% and was observed in both the Cd15 and Pb150 groups, with higher reductions observed in
the Cd15 + Pb150 group (20 to 30%), corroborating possible additive effects of these metals. Our results
are in agreement with other researchers using different animal models, route of exposure, and dose
regimes, who also observed RBC, HGB, and HCT reductions [28,29,57–59,62,65]. We can assume that
the reason for RBC, HGB, and HCT decreasing might be intravascular hemolysis since we measured
high values of both metals in the rats’ blood in comparison to the control. Acute treatments of
investigated toxic metals did not change MCV or MCHC, which is line with other authors [25,28,59].
Results from hemoglobin, MCV, and MCHC analysis indicated that both toxic metals may cause
normocytic normochromic anemia, even after acute exposure. One of the possible mechanisms of
metals-induced hemolysis is oxidative stress induction. Free radical production and lipid peroxidation
induced by acute Cd treatment were implicated in RBC hemolysis and anemia in a study using Wistar
rats treated by a single i.p. injection of 2 mg/kg b.w. CdCl2 [57]. Additionally, it is well-known that
Pb binds to -SH groups of different proteins, including enzymes, and subsequently depresses the
activity some of them, namely SOD and CAT [7,10,66] and produces a significant MDA and H2O2
increase in RBC accompanied with reduced glutathione levels [61]. The occurrence of early signs of
oxidative stress in our study was observed after mixture treatment, through increased plasma LPO
levels expressed as malondialdehyde (MDA). Furthermore, treatment with a higher Cd dose produced
significant MDA elevation. These findings are consistent with our previous work, which revealed a
significance increase of MDA levels in plasma after one Cd dose given orally (30 mg/kg b.w.) and
i.p. (1.5 mg/kg b.w.) [42]. Apart from the lipid peroxidation of polyunsaturated membrane lipids,
toxic metals can also produce oxidative damage of proteins, leading to AOPP generation, as shown in
our previous study in rats [42]. In the present study, mixture treatment generated high plasma AOPP
levels in contrast to all other experimental groups. Our results suggest that the effect of combined
exposure to Cd and Pb resulted in a more pronounced negative effect in plasma versus individual
metals, pointing to a possible additive effect. Total antioxidant status expressed as an additive effect
of antioxidant molecules [48] was diminished in the blood of all treated groups, while TOS levels
(including reactive oxygen metabolites, such as hydrogen peroxide and lipid hydroperoxides) were
only elevated after single metal treatment with 30 mg/kg b.w Cd and 150 mg/kg b.w. Pb. In line
with these results, OSI values were significantly elevated in plasma from the Cd30 group, as well as
the Pb150 group, compared to the control. Toxic metal interference with the antioxidant system and
resulting increased free radical load are reasons for the trend we observed in TAS and TOS values.
Similar observations were noticed by Olisekodiaka et al. [67] and Buha et al. [42].
The two doses of Cd in the present work elicited contrasting results on platelets values. The lower
dose of Cd (15 mg/kg b.w.) produced thrombocytosis in contrast to thrombocytopenia that was
achieved with the higher Cd dose (30 mg/kg b.w.). The literature is somewhat conflicting, with some
studies pointing to unchanged levels of PLT after acute or subacute treatment [26,68], and others
showing a decrease in PLT account [28,57,59]. Thrombocytosis observed following administration of
the lower Cd dose may be the result of inflammation, which is supported by the results from the WBC
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count, or as reactive thrombocytosis, which is transient and returns to normal after removal of the
toxicant. Administration of the higher Cd dose or the single Pb dose resulted in thrombocytopenia.
As we have previously mentioned, high concentrations of both metals were measured in the spleen
(unpublished data), thus direct toxic effects of these metals on PLTs in the spleen represent a mechanism
which explains the effects we observed. Interestingly, a mixture of Cd and Pb led to an attenuated
effect of both metals given as single chemicals, which resulted in platelet values similar to the control
group. In support of these findings, we have observed increasing spleen body mass in the Cd30 and
Pb150 group, while it was not changed in the mixture group (data are not shown). Similar results with
no changes in platelet count were observed in sub-chronic mixture studies cared out by Yuan et al. [24]
and Cobbina et al. [25]. This finding suggests a possible antagonistic interaction of these two metals on
the levels of PLT count.
4.2. Effects on Liver
In the present study, a significantly increased accumulation of Cd and Pb was observed in the liver.
The concentration of Cd measured in the tissue correlated with the dose of Cd administered in that the
30 mg/kg b.w. Cd group had a Cd concentration in the liver that was twice as high as the 15 mg/kg b.w.
dose. Measured levels of Cd in the liver were higher than in the blood or kidney, which was expected
based on the route of administration and the duration of exposure used in the study. Additionally,
the reason for this distribution is the high metallothionein (MT) synthesis in the liver [19,69]. Measured
Cd concentration in the liver of the experimental group that received the mixture did not statistically
differ from the individual dose regime, while Pb concentration was three times higher when compared
to the single dose group. The obtained results are consistent with the measured levels of Cd and Pb in
the blood after mixture administration (Cd level was in line with control group, while Pb level was
higher than a single dose). Similar results were obtained in a fifteen-day study on rats i.p. treated
with 0.05 mg Cd/kg b.w., 0.05 mg Pb/kg b.w., and a combined treatment of 0.025 mg Cd/kg b.w. +
0.025 mg Pb/kg b.w. [39], where after mixture treatment levels of Cd and Pb in the liver were in line
with single dose regimes. A possible reason for this observation might be toxicokinetic interactions
between these two metals on the level of intestinal absorption, and thereby modified distribution in
blood and tissues. Divalent cation transporter (DCT1), also known as DMT1, is one of the carriers and
a possible participant in the interaction between toxic metals [70].
Although the exact mechanisms involved in Cd and Pb hepatotoxicity are not fully understood,
their ability to alter oxidative status is significant. In the present study, we observed high
AOPP levels after single metal treatments accompanied with a TAS fall, while MDA levels were
unchanged. The strongest TAS decrease was observed in the Pb150 group. Contrary to these results,
Djukic-Cosic et al. [71], after 6h of a single Cd dose (20 mg/kg b.w), applied orally, observed MDA
increasing in mice liver, but decreasing after 48 h, while Pillai et al. [39] reported an increase in TBARS
levels after mixture and single Cd, but not after single Pb treatment administered i.p. 15 days. Moreover,
no significant changes were observed in MDA and AOPP liver levels after mixture administration.
Our results are consistent with results obtained by Cobbina et al. [25] and Masso et al. [40], who did
not find any MDA/TBARS increase in the liver of animals treated with a Cd and Pb mixture. Despite
the fact that Cd and Pb given individually induced some oxidative damage in the liver, the lack of
the effects of Pb and Cd co-exposure may be at least partly explained by the role of MT and smaller
proportion of free metal able to lead to the oxidative stress disturbance [7]. Metallothioneins exist
in four major forms and are present in different tissues. Synthesis of metallothionein stimulates
both investigated toxic metals, although Cd in a more profound manner. By binding to toxic metals,
MT protects tissues from being affected by metal ions. The Cd-MT complex is primarily formed in the
liver and then slowly released into the circulation and reaches the kidneys [7,19,56].
Changes in serum total protein values may indicate liver dysfunction as the liver is the main
site of plasma proteins synthesis, primarily albumin [72]. Significantly lower values of total proteins
and albumin were observed after mixture treatment, while single metals were not able to produce
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any change. Histopathological analysis did not reveal a serious disturbance of the liver structure that
would lead to enzyme release. In line with this, we did not observe any elevation in serum AST and
ALT activities. Contrary, both enzymes surprisingly showed a decreasing trend, but with significance
only in the ALT activities of Cd30 and both Pb groups. While other authors recorded enzymes
elevation [24–26], only a few record a decrease [73–75]. The observed decrease can be explained by
the competition between toxic metals and divalent ions, such as Mg, Co, and Mn; activators of the
enzyme; and Zn, a constituent of the enzyme [72]. This is supported by the fact that we measured lower
serum values of Mg in all treated groups, with the most pronounced reduction in groups treated with
Pb. Interaction between toxic metals and bioelements has been extensively studied by our research
group and these studies confirmed many hypotheses; prolonged oral exposure to Cd significantly
reduced Zn levels in blood and nine organs; Cd interferes with intestinal Mg absorption and affects
its homeostasis; and Cd exposure results in negative effects on Mg, Zn, Cu, and even iron tissue
levels [12–14,41,42,76,77].
4.3. Effects on Kidneys
In line with Cd doses, the experimental group that received 30 mg Cd/kg b.w. had a higher
concentration in kidneys when compared to a lower Cd dose (73.5%). After mixture exposure,
measured levels of toxic metals in the kidneys were higher than after single metal treatments. Possible
explanations might be the excretory function of the kidney and rich blood supply and secondly, the role
of the MT [2,78]. The formed Cd-MT complex is slowly released from the liver into the circulation
and reaches the kidneys. After filtration in the kidneys, Cd is reabsorbed in proximal tubules and
deposited in the kidneys. Metallothionein dissolves by discharging the free metals form capable of
producing damage [7,19,56].
In the present work, higher Cd doses produced a more robust MDA elevation in kidneys compared
to lower doses, yet these changes were not statistically significant compared to control values. On the
other hand, Pb treatments increased kidneys MDA levels in comparison to the control, while the
after mixture treatments increase was significant when compared to controls and the Cd15 group.
Obtained results were similar to the results of other studies [28,29,59,62,79,80]. On the other hand,
sub-chronic exposure to low Cd and Pb doses given as a single dose (0.005 mg Cd/L and 0.01 mg
Pb/L), as well as a mixture through free drinking water [25], did not produce any changes in MDA
levels in mice kidneys. The different study design, the path of exposure, the dose, as well as the
applied chemical form of metals are some of the possible explanations for the different results obtained
between researchers. As we have already mentioned, many researches have shown that both metals
lead to the formation of oxidative stress, whether applied individually or together, with different doses
and exposure pathways, as recently reviewed by Matovic´ et al. [7]. Obtained results for MDA levels
suggest that the effect of combined exposure to Cd and Pb resulted in a more pronounced negative
effect in kidneys versus the effects of individual metals, which is contrary to the results obtained in the
liver. The changes we observed correlate with the changes in measured Cd and Pb concentrations in
the kidneys after administration of the metal mixture. Once again, the role and presence of MT could
be important for these findings [7]. Additivity or synergism is a well-known scenario in co-exposure
to Cd and Pb in kidneys. However, the limitation of our study is the fact that our study design is
inadequate for interaction evaluation according to the criteria given by Borgert et al. [81], so we can
only claim additivity.
The renal profile parameter, urea, significantly decreased in all experimental dosage regimes,
compared to untreated animals, while creatinine levels exhibited an increasing trend. Changes in
urea and creatinine levels indicate that even after the administration of a single dose of toxic metals,
the excretory function of the kidney might be impaired. Similar results of changes in the levels of
urea and creatinine were observed in other studies [24–26,28]. Impaired excretory function is also
supported by the fact that levels of some serum ions have been changed (Ca, Mg, P, and Cl), as well as
levels of Cu and Zn in the blood and kidneys. The strongest decreasing in serum levels of Ca and Mg
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was observed after mixture treatment in comparison to the control group. On the other hand, a single
Cd dose (30 mg/kg b.w.) had a more prominent effect on the serum P level in blood, while a single
Pb dose had a more pronounced effect on the Cl level. Additionally, a single dose of Cd (30 mg/kg
b.w.) significantly decreased the Zn level in the blood, while all dose regimes decreased the kidney
Zn levels.
5. Conclusions
Our results showed that acute exposure to Cd and/or Pb induced toxic effects in the blood, liver,
and kidneys of adult Wistar rats. Oxidative stress is a major mechanism of toxicity for both metals
and was implicated as a significant factor in our study, having observed a disturbed redox status in
investigated tissues of treated rats. This study also showed a more profound toxicity of metal mixtures.
Future studies should be focused on subacute or subchronic exposure to these metals and designed to
enable interaction assessment.
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